GenMark Diagnostics Inc. (GNMK) announced after the bell Monday that it now expects to report full year 2013 revenues of approximately $30 million, down from its original estimate of approximately $35 million. The consensus estimate is for revenues of $35.11 million.
GenMark Diagnostics gapped open lower Tuesday and fell in early trade, before settling into a range. Shares finished with a loss of 1.40 at $9.57 on above average volume. The stock sank to a 5-month low.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.